Study To Determine The Effects And Safety Of A Weight Loss Compound On Overweight, Otherwise Healthy, Volunteers

Status:
Completed

Trial end date:
2008-01-01

Target enrollment:

Participant gender:

The purpose of this study is to determine whether CP-866,087 is effective in the weight loss of overweight patients.

Phase 2

Pfizer